SUMMARY One hundred non-smoking patients attending hospital outpatient clinics reported their degree of passive exposure to tobacco smoke over the preceding three days and provided samples of blood, expired air, saliva, and urine. Although the absolute levels were low, the concentration of cotinine in all body compartments surveyed was systematically related to self reported exposure. Salivary nicotine concentration also showed a linear increase with degree of reported exposure, although this measure was sensitive only to exposure on the day of testing. Measures of carbon monoxide, thiocyanate, and plasma nicotine concentrations were unrelated to exposure. The data indicate that cotinine provides a valid marker of the dose received from passive smoke exposure. The non-invasive samples of urine and saliva are particularly suited to epidemiological investigations. Detailed questionnaire items may also give valuable information.
There has been increasing concern in recent years that non-smokers chronically exposed to tobacco smoke in their daily lives may suffer a significant risk to their health. Adults so exposed have been reported to have impaired lung function ' and Epidemiological investigation of the risks of passive smoking required both a reliable non-invasive marker and validated questionnaire measures for assessing the degree of exposure. While COHb has been found to be of use in short term studies, it is not specific to tobacco smoke and may not be sufficiently sensitive to reflect the variety of exposures occurring in daily life. Thiocyanate may likewise suffer from a lack of specificity and sensitivity. Nicotine is specific to tobacco but has a short half life in plasma, and its major metabolite, cotinine, may provide a better guide. We have examined the levels of all these markers and their relation to self report by questionnaire in non-smokers whose exposure to tobacco smoke was not artificially manipulated in any way. The results have implications both for the choice of biochemical marker for the study of passive smoke exposure and for the validity of questionnaire measures of exposure.
Subjects and methods
The subjects were 100 non-smokers (mean age 56&8, SD 10 1) drawn from a sample of 215 patients attending cardiology and vascular outpatient clinics at St Mary's Hospital, London, who filled in a smoking questionnaire and provided samples of 335 M Jarvis, H Tunstall-Pedoe, C Feyerabend, C Vesey, and Y Salloojee blood, expired air, saliva, and urine. The non-smokers were defined as those who reported no smoking of cigarettes, pipes or cigars and whose levels of plasma cotinine were below 20 ng/ml. The latter requirement resulted in the exclusion of 21 self reported non-smokers whose levels of biochemical markers were similar to those found in the self-reported smokers and were therefore incompatible with their claimed non-smoking status (table 1). 
Results
The mean concentration of each marker in the non-smokers, smokers, and deceivers is shown in table 1. The average value in the deceivers was in each case much higher than in the non-smokers and did not differ significantly from the smokers' level for seven of the nine markers measured. The lowest concentration of plasma cotinine encountered in the deceivers was over three times higher than the highest in the non-smokers, and this subject also had a plasma nicotine concentration of 10-5 ng/ml, close to the mean for all self-reported smokers. On average the concentration of cotinine, whether measured in plasma, saliva or urine, was about 200 times higher in the smokers and the deceivers than in the non-smokers. Table 2 shows for the non-smokers the mean concentration of each marker by degree of self reported smoke exposure. Almost half of the subjects reported no exposure at all in the past three days, and only 7% reported heavy exposure.
The concentration of cotinine in each body fluid measured showed significant variation with exposure. This was not just due to a difference between those who reported any exposure versus (fig 2) . For the other variables there was no clearcut -15 relation between time of day and the measured concentration, although there was a tendency for 10 plasma cotinine levels to be higher in afternoon attenders (p = 0-056) . the past three days. Furthermore, non-invasive samples of saliva and urine provided essentially the same information as did invasive and less easily gathered blood samples and for epidemiological applications may be preferable. Our data showed a high degree of intercorrelation between the concentration of cotinine in urine and saliva and do not permit a recommendation of one sample over the other. However, we note two recent publications which indicate that urinary cotinine may be the marker of choice.14 15
Nicotine measures also showed some relation to self reported exposure, although not in plasma and only marginally in urine. The concentration of nicotine in saliva was related to exposure, but only exposure on the day of testing. These differences reflect the metabolism and excretion of nicotine. Nicotine in plasma has a short half-life at about 2 hours, being metabolised to cotinine, which has a half-life in non-smokers of about 12 hours,16 and being concentrated and excreted in saliva and urine.
Exclusion of subjects whose self reported smoking status was at variance with their measured concentrations of biochemical markers was necessitated by the problem of deception among patients attending clinics through smoking related disease. Although categorisation of the "deceivers" was by reference only to plasma cotinine, it is important to note that they had raised values of all markers measured. Comparison with data from experimental studies of exposure to abnormally smoky atmospheres shows that markers are raised, but still only by a small fraction of the active smoking dose. Jarvis et al estimated that after 2 hours' exposure in a very smoky public house only between one tenth and one third of one cigarette-equivalent of nicotine had been absorbed.8 It is therefore biologically implausible that a pattern of markers consistently raised to levels similar to those in active smokers could be seen in passive smokers, however chronically exposed. Furthermore, we stress that the exclusion of the deceivers was conservative with repect to establishing a relation between measures of smoke absorption and self reported passive exposure, since they typically reported high levels of passive exposure ("A lot" 10: "Some" 6; "Just a little" 2; "None at all" 3).
The mean levels of each biochemical marker in this sample of non-smokers were low. Average cotinine and nicotine concentrations were similar to those found in a group of non-smokers who had been specifically requested to avoid all contact with tobacco smoke in the day before sampling,8 and the concentration of nicotine in urine and saliva in those who attended in the afternoon was about 50% lower than Feyerabend et at9 found in non-smokers on the afternoon of a normal working day. This probably reflects the fact that the present sample consisted mainly of elderly subjects, many of whom led restricted lives because of chronic illness. That clear relations between self reported exposure and smoke absorption emerged despite this range restriction suggests that such effects might be stronger in more representative samples.
The average concentration of cotinine, whether measured in plasma,saliva or urine, lay between one third and one half of 1% of the levels found in the smokers in this study and might therefore be regarded as trivial. However, since a dose-response relation to passive exposure was found, some individuals had received a higher proportion of a smoking dose, and it is possible that they may have received larger, and clinically more significant, doses of compounds which we did not measure Epidemiological studies of the health risks of passive smoking have at best used global self-report to categorise non-smokers as exposed or non-exposed, and in some cases have used indirect inference. For example, in the important Japanese study,2 wives' status as exposed or non-exposed was inferred from their husbands' smoking habits, and the degree of exposure of the wife was crudely indexed by the number of cigarettes her husband smoked per day. The potential for misclassification that this method poses is indicated by the fact that a recent study found that 30% of persons married to smokers reported no passive smoke exposure.18 These observations throw doubt on the accuracy of categorisation by inference. Nevertheless the present data suggest that detailed questions about recent exposure provide valid information and can usefully supplement the information gained from biochemical markers.
We conclude that valid non-invasive markers of passive exposure to tobacco smoke in non-smokers are available and should be used in epidemiological investigations of the health risks of passive smoking. They can usefully be supplemented by detailed questionnaire measures.
